燒傷護理市場 - 按產品類型、燒傷深度、最終用途 - 全球預測

Burn Care Market - By Product Type, By Depth of Burn, By End-use - Global Forecast

出版日期: 2024年05月23日 | 出版商:

Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

在政府支持性政策、燒傷護理研究資金以及提高燒傷治療機會的公眾意識活動的推動下，全球燒傷護理市場從 2024 年到 2032 年將呈現 7.4% 的複合年成長率。政府政策和財政支持促進了燒傷治療技術的先進研究和開發，從而產生創新的產品和療法。由政府資助的公眾意識活動和教育計劃增加了有關燒傷預防和及時治療重要性的知識。此外，政府補貼和資金加強了醫療保健基礎設施，確保更好地獲得燒傷護理服務，特別是在服務不足的地區。

舉個例子，2024年1月，生物治療公司MediWound從美國國防部獲得了670萬美元的追加資金，用於為美國陸軍提供非手術燒傷治療。這一增加使總預算達到 1440 萬美元，促進 NexoBrid 溫度穩定版本的開發。 MediWound 旨在將 NexoBrid 定位為治療院前環境中嚴重燒傷的主要非手術解決方案。這種創新的生物製劑旨在去除嚴重燒傷的焦痂，為手術方法提供了一種經濟高效的替代方案，最大限度地減少了相關成本和併發症。

此類措施也促進了燒傷管理方面醫療專業人員的培訓，改善患者的治療效果並進一步推動市場成長。

整個燒傷護理市場根據產品類型、燒傷深度、最終用途和地區進行分類。

在生物製劑治療嚴重燒傷的先進治療特性和有效性的推動下，到 2032 年，生物製劑領域將佔據相當大的市場佔有率。生物製劑為傷口癒合和組織再生提供創新的解決方案，解決傳統治療的限制。它們能夠促進快速有效的康復、降低感染風險並最大限度地減少手術干預的需要，這使得它們備受追捧。此外，持續的研究和開發，加上人們對生物製劑的認知和接受度不斷提高，也增強了它們的採用。政府對生物療法的資助和監管支持進一步推動其市場需求，為複雜的燒傷護理挑戰提供先進、經濟高效的解決方案。

到 2032 年，診所可能會成為燒傷護理行業的重要最終用戶。他們提供先進治療（包括傷口護理和皮膚移植）的能力推動了他們的吸引力。患者對門診護理的偏好增加，加上燒傷發生率上升，增加了對診所服務的需求。此外，技術進步和醫療基礎設施的改善使診所能夠提供最先進的燒傷治療。成本效益和本地護理的便利性進一步促進了診所在燒傷護理市場中日益重要的作用。

到2032年，亞太燒傷護理市場將錄得健康估值。擴大醫療基礎設施和改善醫療服務的可近性提高了燒傷治療的可用性。隨著人們對燒傷預防和治療的認知和教育不斷提高，政府對燒傷護理計劃的措施和資金進一步支持了市場成長。此外，該地區日益關注醫療保健設施現代化和採用創新技術，有助於更多採用先進的燒傷護理產品和服務。

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 9 章：公司簡介

3M Company
B. Braun Melsungen AG
Cardinal Health
Coloplast
ConvaTec Inc.
DeRoyal Industries, Inc.
Hollister Incorporated
Integra LifeSciences Corporation
Johnson & Johnson
Klinion
Medline Industries, LP
MIMEDX Group, Inc.
Molnlycke Health Care AB
Safetec of America, Inc.
Smith & Nephew

簡介目錄

Product Code: 1857

Global Burn Care Market will exhibit 7.4% CAGR from 2024 to 2032, driven by supportive government policies, funding for burn care research, and public awareness campaigns enhancing access to burn treatment. Government policies and financial backing facilitate advanced research and development in burn treatment technologies, leading to innovative products and therapies. Public awareness campaigns and educational programs funded by governments increase knowledge about burn prevention and the importance of timely treatment. Additionally, government subsidies and funding enhance healthcare infrastructure, ensuring better accessibility to burn care services, especially in underserved areas.

Quoting an instance, In January 2024, MediWound, a biotherapeutics company, secured additional funding of $6.7 million from the US Department of Defense to facilitate its non-surgical burn treatment for the US Army. This boost raises the total budget to $14.4 million, facilitating the development of a temperature-stable version of NexoBrid. MediWound aims to position NexoBrid as the primary non-surgical solution for treating severe burns in pre-hospital environments. This innovative biologic, designed to remove eschar from severe burns, offers a cost-effective alternative to surgical methods, minimizing related costs and complications.

Such initiatives also promote training for medical professionals in burn management, improving patient outcomes and further driving market growth.

The overall burn care market is categorized based on product type, depth of burn, end-use, and region.

The biologics segment will capture a decent market share by 2032, driven by the advanced therapeutic properties and effectiveness of biologics in treating severe burns. Biologics offer innovative solutions for wound healing and tissue regeneration, addressing the limitations of traditional treatments. Their ability to promote rapid and effective recovery, reduce infection risks, and minimize the need for surgical interventions makes them highly sought after. Additionally, ongoing research and development, coupled with increasing awareness and acceptance of biologics, enhance their adoption. Government funding and regulatory support for biologic therapies further propel their market demand, offering advanced, cost-effective solutions for complex burn care challenges.

Clinics could emerge as a prominent end-user across the burn care industry by 2032. Clinics offer specialized, accessible, and patient-centered care, making them ideal for managing burn injuries. Their ability to provide advanced treatments, including wound care and skin grafts, drives their appeal. Increased patient preference for outpatient care, coupled with the rising prevalence of burn injuries, boosts demand for clinic-based services. In addition, technological advancements and improved healthcare infrastructure enable clinics to offer state-of-the-art burn treatments. Cost-effectiveness and the convenience of localized care further contribute to the growing role of clinics in the burn care market.

Asia Pacific burn care market will record a healthy valuation by 2032. Rapid urbanization and industrialization lead to increased burn injuries, driving demand for advanced burn care solutions. Expanding healthcare infrastructure and improving access to medical services enhance the availability of burn treatments. Government initiatives and funding for burn care programs, in line with rising awareness and education about burn prevention and treatment, further support market growth. Additionally, the region's growing focus on modernizing healthcare facilities and adopting innovative technologies contributes to the increased adoption of advanced burn care products and services.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising incidence of burns
  - 3.2.1.2 Advancements in burn care technologies
  - 3.2.1.3 Growing awareness and education
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Stringent regulatory requirements
3.3 Growth potential analysis
3.4 Reimbursement scenario
3.5 Regulatory landscape
3.6 Technological landscape
3.7 Future market trends
3.8 Pricing analysis
3.9 Porter's analysis
3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Advanced dressing
- 5.2.1 Alginate dressing
- 5.2.2 Collagen dressing
- 5.2.3 Hydrogel dressing
- 5.2.4 Hydrocolloid dressing
- 5.2.5 Wound contact layers
- 5.2.6 Film dressing
- 5.2.7 Foam dressing
5.3 Traditional dressing
5.4 Biologics
5.5 Other product types

Chapter 6 Market Estimates and Forecast, By Depth Of Burn, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Full thickness burns
6.3 Partial thickness burns
6.4 Minor burns

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals
7.3 Clinics
7.4 Homecare settings
7.5 Ambulatory surgical centers (ASCs)
7.6 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa